/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

SeaStar Medical Holding Corp

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$0.335 0(0%) ICU at 04 Dec 2025 04:34 PM Biotechnology
Lowest Today 0.3216
Highest Today 0.349
Today’s Open 0.3271
Prev. Close 0.34
52 Week High 3.07
52 Week Low 0.29
Day’s Range: Low 0.3216 High 0.349
52-Week Range: Low 0.29 High 3.07
1 day return -
1 Week return +10.88
1 month return -32.39
3 month return -57.73
6 month return -70.79
1 year return -86.37
3 year return -99.69
5 year return -
10 year return -

Institutional Holdings

UBS Group AG 0.33

Vanguard Institutional Extnd Mkt Idx Tr 0.26

Geode Capital Management, LLC 0.25

XTX Topco Ltd 0.22

Vanguard Group Inc 0.21

Fidelity Extended Market Index 0.18

Virtu Financial LLC 0.14

Tyche Wealth Partners LLC 0.14

PNC Financial Services Group Inc 0.06

Trinity Financial Advisors, LLC 0.05

Northern Trust Corp 0.05

Goldman Sachs Group Inc 0.04

Fidelity Series Total Market Index 0.04

GREAT VALLEY ADVISOR GROUP, INC. 0.04

Northern Trust Extended Eq Market Idx 0.03

NT Ext Equity Mkt Idx Fd - L 0.03

BlackRock Inc 0.03

Fidelity Total Market Index 0.03

Extended Equity Market Fund K 0.03

Tower Research Capital LLC 0.02

Spartan Total Market Index Pool G 0.02

Whittier Trust Co 0.02

Fidelity Nasdaq Composite Index 0.02

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Advisor Group Holdings, Inc. 0.01

Vanguard U.S. Eq Idx £ Acc 0.01

Extended Equity Market Fund M 0.00

Ronald Blue Trust, Inc. 0.00

Morgan Stanley - Brokerage Accounts 0.00

NT Ext Eq Mkt Indx Fd DC Lend T3 0.00

Spartan Extended Market Index Pool F 0.00

Goss Wealth Management LLC 0.00

TD Waterhouse Canada Inc 0.00

Northern Trust Wilshire 5000 0.00

TSFG, LLC 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 11.59 M

PB Ratio 0.9955

PE Ratio 0.0

Enterprise Value 6.48 M

Total Assets 4.66 M

Volume 1546512

Company Financials

Annual Revenue FY24:null 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY24:-26232000 -26.2M, FY23:-35572000 -35.6M, FY22:-23013000 -23.0M, FY21:-4596000 -4.6M, FY20:-3276000 -3.3M

Quarterly Revenue Q3/2025:183000 0.2M, Q2/2025:338000 0.3M, Q1/2025:293000 0.3M, Q3/2024:68000 0.1M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:169000 0.2M, Q2/2025:311000 0.3M, Q1/2025:293000 0.3M, Q3/2024:68000 0.1M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-3472000 -3.5M, Q2/2025:-2002000 -2.0M, Q1/2025:-3772000 -3.8M, Q3/2024:-4478000 -4.5M, Q2/2024:-3236000 -3.2M

Fund house & investment objective

Company Information SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Mr. Eric Schlorff

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow